Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 Jun;15(6):747–753. doi: 10.1128/aac.15.6.747

Mechanism and Specificity of Action of Ribavirin

Michael J Browne 1
PMCID: PMC352752  PMID: 475358

Abstract

Ribavirin at a concentration of 30 μg/ml added immediately after infection completely inhibited influenza A/Port Chalmers/1/73 (H3N2) virus hemagglutinin production in infected MDCK cells. Under these conditions, host cell protein synthesis was inhibited by only 10 to 20%. Polyacrylamide gel electrophoresis of [35S]methionine-labeled material from virus-infected cultures confirmed that ribavirin inhibited viral but not host cell protein synthesis. In parallel experiments, actinomycin D also preferentially inhibited viral protein synthesis. The possibility that ribavirin inhibited viral protein synthesis as a result of general inhibition of ribonucleic acid synthesis was therefore examined. In uninfected cells, ribavirin at 30 μg/ml inhibited the incorporation of [14C]inosine or [3H]uridine into ribonucleic acid but stimulated the incorporation of [3H]guanosine. The effects noted are consistent with an inhibition of the host cell enzyme inosine 5′-monophosphate dehydrogenase. This suggestion is supported by the finding that addition of guanosine, but not inosine, to the culture medium substantially reversed the antiviral effect of ribavirin. There was no separation between the concentration of ribavirin causing inhibition of influenza A viral protein synthesis or inhibition of MDCK cell ribonucleic acid synthesis, suggesting that ribavirin is not specifically antiviral in this system but inhibits viral protein synthesis as a result of the general inhibition of ribonucleic acid synthesis.

Full text

PDF
747

Images in this article

749Image
on p.749

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonner W. M., Laskey R. A. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Eur J Biochem. 1974 Jul 1;46(1):83–88. doi: 10.1111/j.1432-1033.1974.tb03599.x. [DOI] [PubMed] [Google Scholar]
  2. Chow N. L., Simpson R. W. RNA-dependent RNA polymerase activity associated with virions and subviral particles of myxoviruses. Proc Natl Acad Sci U S A. 1971 Apr;68(4):752–756. doi: 10.1073/pnas.68.4.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cochran K. W., Maassab H. F., Tsunoda A., Berlin B. S. Studies on the antiviral activity of amantadine hydrochloride. Ann N Y Acad Sci. 1965 Jul 30;130(1):432–439. doi: 10.1111/j.1749-6632.1965.tb12579.x. [DOI] [PubMed] [Google Scholar]
  4. Cooper H. L., Braverman R. The mechanism by which actinomycin D inhibits protein synthesis in animal cells. Nature. 1977 Oct 6;269(5628):527–529. doi: 10.1038/269527a0. [DOI] [PubMed] [Google Scholar]
  5. De Cercq E., Luczak M. Fluoroimidazoles as antiviral agents and inhibitors of polynucleotide biosynthesis. Life Sci. 1975 Jul 15;17(2):187–194. doi: 10.1016/0024-3205(75)90502-0. [DOI] [PubMed] [Google Scholar]
  6. Eriksson B., Helgstrand E., Johansson N. G., Larsson A., Misiorny A., Norén J. O., Philipson L., Stenberg K., Stening G., Stridh S. Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother. 1977 Jun;11(6):946–951. doi: 10.1128/aac.11.6.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Herrmann E. C., Jr, Herrmann J. A. A working hypothesis--virus resistance development as an indicator of specific antiviral activity. Ann N Y Acad Sci. 1977 Mar 4;284:632–637. doi: 10.1111/j.1749-6632.1977.tb21997.x. [DOI] [PubMed] [Google Scholar]
  8. Huffman J. H., Sidwell R. W., Khare G. P., Witkowski J. T., Allen L. B., Robins R. K. In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses. Antimicrob Agents Chemother. 1973 Feb;3(2):235–241. doi: 10.1128/aac.3.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  10. Lamb R. A., Choppin P. W. Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology. 1976 Oct 15;74(2):504–519. doi: 10.1016/0042-6822(76)90356-1. [DOI] [PubMed] [Google Scholar]
  11. Minor P. D., Dimmock N. J. Inhibition of synthesis of influenza virus proteins: evidence of two host-cell-dependent events during multiplication. Virology. 1975 Sep;67(1):114–123. doi: 10.1016/0042-6822(75)90409-2. [DOI] [PubMed] [Google Scholar]
  12. Minor P. D., Dimmock N. J. Selective inhibition of influenza virus protein synthesis by inhibitors of DNA function. Virology. 1977 May 15;78(2):393–406. doi: 10.1016/0042-6822(77)90116-7. [DOI] [PubMed] [Google Scholar]
  13. Müller W. E., Maidhof A., Taschner H., Zahn R. K. Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent. Biochem Pharmacol. 1977 Jun 1;26(11):1071–1075. doi: 10.1016/0006-2952(77)90246-5. [DOI] [PubMed] [Google Scholar]
  14. Oxford J. S. Effects of 1-beta-D-ribofuranosyl 1, 2, 4-triazole-3-carboxamide on influenza virus replication and polypeptide synthesis. J Antimicrob Chemother. 1975 Dec;1(4 Suppl):71–76. doi: 10.1093/jac/1.suppl_4.71. [DOI] [PubMed] [Google Scholar]
  15. Oxford J. S. Inhibition of the replication of influenza A and B viruses by a nucleoside analogue (ribavirin). J Gen Virol. 1975 Sep;28(3):409–414. doi: 10.1099/0022-1317-28-3-409. [DOI] [PubMed] [Google Scholar]
  16. Scholtissek C. Inhibition of influenza RNA synthesis by virazole (ribavirin). Arch Virol. 1976;50(4):349–352. doi: 10.1007/BF01317961. [DOI] [PubMed] [Google Scholar]
  17. Sidwell R. W., Huffman J. H., Khare G. P., Allen L. B., Witkowski J. T., Robins R. K. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science. 1972 Aug 25;177(4050):705–706. doi: 10.1126/science.177.4050.705. [DOI] [PubMed] [Google Scholar]
  18. Streeter D. G., Witkowski J. T., Khare G. P., Sidwell R. W., Bauer R. J., Robins R. K., Simon L. N. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci U S A. 1973 Apr;70(4):1174–1178. doi: 10.1073/pnas.70.4.1174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tobita K., Sugiura A., Enomote C., Furuyama M. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med Microbiol Immunol. 1975 Dec 30;162(1):9–14. doi: 10.1007/BF02123572. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES